CAS: 1617-68-1; [(1R,3Ar,5Ar,5Br,7Ar,9S,11Ar,11Br,13Ar,13Br)-3A,5A,5B,8,8,11A-Hexamethyl-1-Prop-1-En-2-Yl-1,2,3,4,5,6,7,7A,9,10,11,11B,12,13,13A,13B-Hexadecahydrocyclopenta[a]Chrysen-9-Yl] Acetate
该化合物是一种属于三叶类的化学化合物,具体地说是一种乳腺类化合物,其特点是四环结构,这是许多天然畸形的典型特征;三处位置和乙酸盐组有氢氧基,有助于其功能性,影响其溶解性和再活性;该化合物经常出现在各种植物提取物中,并研究其潜在的生物活动,包括防炎和抗微生物特性;其结构特征允许其与生物膜相互作用,而生物膜可能在其药理效应中发挥作用;此外,乳腺衍生物在天然产品化学领域很感兴趣,可能用于草药和化妆剂;
- 英文名称[(1R,3Ar,5Ar,5Br,7Ar,9S,11Ar,11Br,13Ar,13Br)-3A,5A,5B,8,8,11A-Hexamethyl-1-Prop-1-En-2-Yl-1,2,3,4,5,6,7,7A,9,10,11,11B,12,13,13A,13B-Hexadecahydrocyclopenta[a]Chrysen-9-Yl] Acetate
- 中文名称乙酸羽扇醇酯
- IUPAC名称Lup-20(29)-en-3-ol, acetate, (3beta)-
- 其它别名Lup-20(29)-en-3b-ol, acetate (8CI); Lup-20(30)-en-3b-ol,acetate (6CI,7CI); 1H-Cyclopenta[a]chrysene, lup-20(29)-en-3-ol deriv.; 3-Acetyllupeol; 3-O-Acetyllupeol; Acetyllupeol; Clerodol acetate; Lup-20(29)-en-3b-ylacetate; Lupeol 3-acetate; Lupeol acetate; Lupeyl acetate
- CAS编号1617-68-1
- MFCD编号:MFCD00017362
- EINECS号:216-575-8
- FDA UNII编号:WJ3A89G0H6
- 分子式:C32H52O2分子量:468.75
- 产品CID: 817038
- 产品分类生物化工 → 提取物
物理性质
上下游产品
lupeol acetic anhydride ethanol 19α-chloro-18α-oleananol-(3β)Lupenylacetat lup-20(30)-ene-3β,29-diol lupenol formaldehyd合成工艺路线路线简述
📜羽扇豆醇置于乙酸酐体系中,用 吡啶 用作溶剂,化学反应 24.0H,反应生成乙酸羽扇醇酯
参考文献:Querspicatins A 和 B,来自 Quercus Spicata 的两种五环三萜
标题:Querspicatins A 和 B,来自 Quercus Spicata 的两种五环三萜
摘要:摘要 从栎属栎的树皮中分离到了两种新的三萜类化合物,分别命名为 Querspicatin A 和 Querspicatin B.它们已被证明是 3β-(3',4'-Dihydroxycinnamoyloxy)-9α-Hydroxy-7-Oxo-Lup-20 (30)-Ene 和 3β,9α-Dihydroxy-7-Oxo-Lup-20(30 )-烯基于其 1 H NMR,13 C NMR 和质谱数据以及化学证据.
Doi:10.1016/0031-9422(89)80361-9
海关参考信息
- 2901210000-乙烯
2901220000-丙烯
2905122000-异丙醇
2909110000-乙醚 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-7858606-B2
优先权日:2000-05-23
标题 :Triterpenoid derivatives
发明人：HAJDUCH MARIAN; SAREK JAN
权利人:UNIV PALACKEHO; UNIV KARLOVA
摘要:The present invention relates to the use of a compound of formula (I), or a pharmaceutically acceptable salt, crystal form, complex, hydrate, or hydrolysable ester thereof, in the preparation of a medicament for treating a patient suffering from leukaemia, cancer or other proliferative disorder. A further embodiment relates to the use a compound of formula (I) in an assay for detecting the phosphorylation state of cellular substrates. The present invention also relates to novel compounds of formula (I), and the chemical synthesis thereof.
专利号:WO-0190046-A1
优先权日:2000-05-23
标 题:Triterpenoid derivatives
发明人：HAJDUCH MARIAN; SAREK JAN
权利人:UNIVERZITA PALACKEHO V OLOMOUC; UNIV KARLOVA; CYCLACEL LTD; HAJDUCH MARIAN; SAREK JAN
摘要:The present invention relates to the use of a compound of formula (I), or a pharmaceutically acceptable salt, crystal form, complex, hydrate, or hydrolysable ester thereof, in the preparation of a medicament for treating a patient suffering from leukaemia, cancer or other proliferative disorder. A further embodiment relates to the use a compound of formula (I) in an assay for detecting the phosphorylation state of cellular substrates. The present invention also relates to novel compounds of formula (I), and the chemical synthesis thereof.
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
主要参考文献
1: Liu GF, Yang SS, Yang ZQ. [Isolation and identification of the lipophilic constituents from the root of Euphorbia fischeriana Steud]. Zhong Yao Tong Bao. 1987 Aug;12(8):36-8, 64. Chinese.
合成参考文献
摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
📝 需求与反馈
尽可能描述清楚需求与问题信息
